|
Day 1: 27February 2012
Keynote Presentation
The Hematopoietic Stem Cell as a Target for Therapy Against
Cancer and AIDS
Dr David Baltimore
-
Nobel Laureate in Medicine and Physiology, & President Emeritus,
Robert Andrews Millikan Professor of Biology, California
Institute of Technology
Session 1: Pluripotent Stem Cells
Realizing the Promises of Pluripotent Stem
Cells: Discovering Fundamental Biological Principles, New
Medical Options and Enriching Friendships via Scientific
Diplomacy Globally
Professor Gerald Schatten
- Pittsburgh Development Center
Mechanisms of Mesoderm Differentiation in
Pluripotent Mammalian Stem Cells
Professor Roger Pedersen
� The Anne Mclaren Laboratory for Regenerative Medicine,
University of Cambridge
Generation of red blood cells from pluripotent stem cells as an
alternative to donated blood.
Dr. Joanne C Mountford-
Scottish National Blood Transfusion Service & University of
Glasgow, UK
Essential Role of P-Selectin in Endothelial Progenitor
Cells-induced Inhibition of Platelet Aggregation and Thrombus
Formation
Dr. Haitham Abu Saleh
- Weill Cornell Medical College in Qatar
Session 2: Transplanting Stem Cells for Diabetes, Liver Failures
& Metabolic Diseases
Clinical Applications of Human Induced Pluripotent: Challenges
and Opportunities.
Ludovic Vallier
- The Anne McLaren Laboratory for Regenerative Medicine,
University of Cambridge
Comprehensive Transcriptome and Proteome
Analysis of Human Embryonic Stem Cells Differentiation to Neural
Cells
Ghasem Hosseini Salekdeh
-Royan Institute for Stem Cell Biology and Technology
Reprogramming Approaches for Human Heart
Disease
Deepak Srivastava
- Gladstone Institute of Cardiovascular Disease, San Francisco
Programming and Reprogramming: New
approaches for Understanding Disease
Chad A. Cowan
- Harvard Stem Cell Institute
Panel Discussion 2: Stem Cell Research in the Middle East
Stem Cell Research; from Promise to Practice
Aida Al Aqeel
� Riyadh Military Hospital
Day 2: 28 February 2012
Keynote Presentation
Normal and Neoplastic Stem Cells
Irving Weissman -
Stanford Institute for Stem Cell Biology and Regenerative
Medicine
Panel Discussion 3: Stem Cell Policy in the Middle East
Overview of Present Guidelines on Stem Cell
Research
Faleh Mohmed Hussein Ali
- Supreme Council of Health, Qatar
Stem Cells on Research- Islamic
Perspectives
Abdulaziz M. Alswailem
- King Abdulaziz City for Science and Technology
Sessions 3: Cord Blood, Hematopoietic Stem Cells and Cancer
Anti-apoptotic, anti-inflammatory and
immunosuppressive effects of mesenchymal stem cells: novel
concept for future therapies
Erdal Karaoz
- Kocaeli University
Cell transplantation in clinical practice:
Royan institute experiences
Nasser Aghdami
- Royan Institute for Stem Cell Biology and Technology
Cardiomyocyte derivation from Human
Embryonic stem cell derived Mesenchymal progenitors
Jeremie Arash Rafii Tabrizi
� Weill Cornell Medical College in Qatar
A study on hemopoisis and differentiation
of dendritic cells from Primitive CD34 Haematopoitic Stem Cells
from CML Patients
Ameera Gaafar
- King Faisal Specialist Hospital and Research Centre
Session 4: Stem Cell Banking
Build it and they will come
Rajan Jethwa
- Virgin Health Bank, Qatar
Umbilical Cord Blood Transplantation: Saudi
Arabia Experience
Hind Al-Humaidan
- King Faisal Special Hospital and Research Centre
Stem Cell Banking: Ethical and Policy
Issues
Nancy King
- School of Medicine, Wake Forest University
An International Perspective on the
Regulation of Biosamples
Sarah Ellson �
Field Fisher Waterhouse LLP
Informed Consent and the Arab-Muslim
Research Participant: Tensions and Challenges
Kartina Aisha Chong
- University of Central Lancashire
Session 5: Embryonic Research and Egg Donations
The Ethical Issues in Human Stem Cell Research: From Principles
to Policy
Laurie Zoloth
- Centre for Bioethics, Health & Society, Northwestern
University
Analysis of human endoderm development
using lineage specific reporter hESCs
Ed Stanley
- Monash Immunology and Stem Cell Laboratories, Monash
University
Understanding the Origins and Impact of the
Heterogeneous Policy Environment for Egg Donation
Aaron Levine
- School of Public Policy, Georgia Tech
Ethical Issues in Egg and Embryo Donation:
Informed Consent
Ana Iltis
- Centre for Bioethics, Health & Society ,Wake Forest University
Day 3: 28 February 2012
Keynote Presentation
Translation of Stem Cell Discoveries in
Regenerative Medicine
Alan Trounson
- President,California Institute for Regenerative medicine
Session 6: Cardiovascular Disease
Therapeutic & Research Potential of Human Stem Cells � The GE
Healthcare Perspective
Stephen Minger
� GE Healthcare Life Sciences, The Maynard Centre
NKX2-5GFP/w human embryonic stem
cells permit the identification of human cardiac progenitor
cells and cardiomyocytes
David Elliot
- Monash Immunology and Stem Cell Laboratories, Monash
University
Dynamics of myocardial perfusion in patients with coronary heart
disease and post infarction cardiosclerosis after stem cell
therapy
Massoud Mirshahi
- Faculty of Medicine, Universite et Marie Curie
Regenerating the Human Heart: Proof of
Principle to Patient- Derived Myocardial Tissue
Heba Al-Siddiqi
- Harvard Stem Cell Institute, member of the QSLP
Session 7: Regulating Stem Cell Research
Professional Guidelines and Approaches to the Ethical Oversight
of Stem Cell Research
Jeremy Sugarman
- Berman Institute of Bioethics, Johns Hopkins University
International Stem Cell Policies
Kirstin Matthews
� James A. Baker III Institute for Public Policy, Rice
University
Conceptual and Practical Considerations for
Material and Data Sharing in Stem Cell Research
Kazuto Kato
- Kyoto University, Japan
Policy Paradoxes: The Commercialization of
Stem Cell Research
Timothy Caulfield
- Faculty of Law & School of Public Health, University of
Alberta
Day 4: 28 February 2012
Keynote Presentation
Presentation on Stem cell and Regenerative Therapy programe at
QCRC
Professor Sir Magdi Yacoub -
Co-Chairman, Qatar Cardiovascular Research Center
Session 8: Neurological Disorders
Secreted Noncoding RNAs and Therapeutic
Neural Stem Cell Pasticity
Stefano Pluchino
� Centre for Brain Repair, University of Cambridge
Clinical Translation of Human Neural Stem
Cells, Promise for the Future
Ann Tsukamoto-Weissman
- Stem Cells Inc
Session 9: Clinical Trial Oversight and Regulation
Establishing a Legal Foundation for Public Oversight of Clinical
Trials
Mark Frankel
- American Association for the Advancement of Science (AAAS)
The tragedy of translation: Epistemological
and ethical challenges pertaining to bringing stem cells to the
clinic
Jan Helge Solbakk-
Centre for Medical Ethics, University of Oslo
A Multiple Perspectives Approach to Stem
Cell-Based Clinical Trials
Insoo Hyun
- School of Medicine, Case Western Reserve University
What we need in the GCC states to catch-up
with evolving Stem Cell and regenerative medicine research
Saleh Al-Othman
�- King Faisal Special Hospital & Research Centre
Reconciling Multiple Standards
Kip Kantelo-
Weill Cornell Medical College in Qatar
|
